Demant A/S (OTCMKTS:WILYY – Get Free Report) was upgraded by equities research analysts at The Goldman Sachs Group to a “strong-buy” rating in a report issued on Monday, Zacks.com reports.
Several other equities analysts have also commented on WILYY. Hsbc Global Res raised Demant A/S to a “hold” rating in a research note on Friday, September 13th. UBS Group raised shares of Demant A/S to a “strong-buy” rating in a research report on Wednesday, August 28th.
Read Our Latest Stock Report on Demant A/S
Demant A/S Stock Performance
Demant A/S Company Profile
Demant A/S operates as a hearing healthcare and audio technology company in Europe, North America, the Asia Pacific, Asia, and internationally. It operates through two segments: Hearing Healthcare and Communications. The Hearing Healthcare segment is involved in the manufacturing, servicing, and sale of hearing aids, and diagnostic products and services.
Featured Stories
- Five stocks we like better than Demant A/S
- What does consumer price index measure?
- Short Sellers Eye Palantir: Should You Buy the Dip?
- Are Penny Stocks a Good Fit for Your Portfolio?
- Is This NVIDIA Backed Robotics Stock a Buy As It Nears Expansion?
- What is a Death Cross in Stocks?
- Bet on These 3 High-Yield Stocks as Natural Gas Demand Grows
Receive News & Ratings for Demant A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Demant A/S and related companies with MarketBeat.com's FREE daily email newsletter.
